From: PROTEOMAS: a workflow enabling harmonized proteomic meta-analysis and proteomic signature mapping
Trait | # Significantly altered GO terms | # Significantly altered KEGG pathways | # Significantly altered REACTOME pathways | # Significantly altered HALLMARK sets |
---|---|---|---|---|
Lung cancer | 1462 | 46 | 181 | 35 |
IPA | 1065 | 42 | 189 | 22 |
CNT NM-400 | 396 | 11 | 44 | 12 |
COPD | 312 | 6 | 110 | 8 |
Drug | 1739 | 47 | 329 | 25 |
CB | 19 | 0 | 6 | 0 |
Co NM | 6 | 1 | 7 | 2 |
Fe NM | 80 | 1 | 18 | 0 |
FeCo NM | 127 | 1 | 30 | 0 |
CNT NM-403 | 201 | 2 | 13 | 3 |
Ag NM | 185 | 6 | 21 | 5 |
Au NM | 417 | 10 | 93 | 9 |
Other CNT | 300 | 6 | 79 | 8 |
CuO NM | 300 | 3 | 65 | 9 |
ND | 145 | 1 | 10 | 1 |
LPS | 140 | 4 | 19 | 7 |
QD | 276 | 8 | 66 | 8 |
TiO2 | 696 | 33 | 171 | 17 |
Virus | 446 | 21 | 73 | 16 |